Trial Outcomes & Findings for Developing and Testing a Personalized Evidence-based Shared Decision-making Tool for Stent Selection (NCT NCT02046902)
NCT ID: NCT02046902
Last Updated: 2019-08-06
Results Overview
The primary outcome was whether or not patients participated in SDM regarding stent choice. Patients were categorized as having participated in SDM if they answered anything other than "doctor alone" in response to the question "Who chose the type of stent?"
COMPLETED
586 participants
30 months
2019-08-06
Participant Flow
Between May 2014 and December 2016, patients were recruited from 2 percutaneous coronary intervention (PCI) centers, Saint Luke's Mid America Heart Institute (MAHI) and Truman Medical Center (TMC), following institutional review board (IRB) approval at each site.
Participant milestones
| Measure |
Pre-Implementation
Patients who undergo coronary angiography and possible percutaneous coronary intervention (PCI) received an Patient Risk Information Systems Manager (ePRISM) consent form with personalized risk estimates for mortality, bleeding, and target vessel revascularization (TVR) with bare-metal stents (BMS) and drug-eluting stents (DES), but neither the shared decision-making (SDM) tool nor decision coaching.
|
Post-implementation With Decision Coaching
Patients received the consent form, the SDM tool for stent selection, and decision coaching
|
Post-implementation Without Decision Coaching
Patients received the consent form and the SDM tool, but no decision coaching
|
|---|---|---|---|
|
Overall Study
STARTED
|
336
|
113
|
137
|
|
Overall Study
COMPLETED
|
336
|
113
|
137
|
|
Overall Study
NOT COMPLETED
|
0
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
Baseline characteristics by cohort
| Measure |
Pre-Implementation
n=336 Participants
Patients who undergo coronary angiography and possible percutaneous coronary intervention (PCI) received an Patient Risk Information Systems Manager (ePRISM) consent form with personalized risk estimates for mortality, bleeding, and target vessel revascularization (TVR) with bare-metal stents (BMS) and drug-eluting stents (DES), but neither the shared decision-making (SDM) tool nor decision coaching.
|
Post-implementation With Decision Coaching
n=113 Participants
Patients received the consent form, the SDM tool for stent selection, and decision coaching
|
Post-implementation Without Decision Coaching
n=137 Participants
patients received the consent form and the SDM tool, but no decision coaching
|
Total
n=586 Participants
Total of all reporting groups
|
|---|---|---|---|---|
|
Age, Continuous
|
66.1 years
STANDARD_DEVIATION 11.8 • n=333 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
67.6 years
STANDARD_DEVIATION 12.9 • n=113 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
68.6 years
STANDARD_DEVIATION 11.6 • n=137 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
67.43 years
STANDARD_DEVIATION 12.1 • n=583 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Sex: Female, Male
Female
|
93 Participants
n=259 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
39 Participants
n=110 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
49 Participants
n=137 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
181 Participants
n=506 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Sex: Female, Male
Male
|
166 Participants
n=259 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
71 Participants
n=110 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
88 Participants
n=137 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
325 Participants
n=506 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=327 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=112 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=135 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=574 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=327 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=112 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
1 Participants
n=135 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
1 Participants
n=574 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=327 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=112 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=135 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=574 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Race (NIH/OMB)
Black or African American
|
77 Participants
n=327 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
21 Participants
n=112 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
18 Participants
n=135 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
116 Participants
n=574 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Race (NIH/OMB)
White
|
250 Participants
n=327 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
91 Participants
n=112 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
116 Participants
n=135 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
457 Participants
n=574 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=327 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=112 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=135 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=574 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=327 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=112 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=135 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=574 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Race/Ethnicity, Customized
Hispanic Ethnicity
|
5 Participants
n=291 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
2 Participants
n=112 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
3 Participants
n=132 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
10 Participants
n=535 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Site
Mid America Heart Insitute
|
191 Participants
n=336 Participants
|
86 Participants
n=113 Participants
|
132 Participants
n=137 Participants
|
409 Participants
n=586 Participants
|
|
Site
Truman Medical Center/Univ. of Missouri KC
|
145 Participants
n=336 Participants
|
27 Participants
n=113 Participants
|
5 Participants
n=137 Participants
|
177 Participants
n=586 Participants
|
|
Diabetes
|
152 Participants
n=335 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
49 Participants
n=113 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
69 Participants
n=131 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
270 Participants
n=579 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Hypertension
|
266 Participants
n=336 Participants
|
92 Participants
n=113 Participants
|
106 Participants
n=137 Participants
|
464 Participants
n=586 Participants
|
|
Peripheral arterial disease
|
29 Participants
n=331 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
22 Participants
n=113 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
20 Participants
n=121 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
71 Participants
n=565 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Prior Coronary Artery Bypass Graft
|
53 Participants
n=334 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
20 Participants
n=113 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
28 Participants
n=127 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
101 Participants
n=574 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Prior Percutaneous Coronary Intervention
|
137 Participants
n=333 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
50 Participants
n=113 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
66 Participants
n=133 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
253 Participants
n=579 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Admission Status
Inpatient
|
116 Participants
n=326 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
44 Participants
n=111 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
57 Participants
n=129 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
217 Participants
n=566 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Admission Status
Outpatient
|
189 Participants
n=326 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
67 Participants
n=111 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
71 Participants
n=129 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
327 Participants
n=566 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
|
Admission Status
Emergent
|
21 Participants
n=326 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
0 Participants
n=111 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
1 Participants
n=129 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
22 Participants
n=566 Participants • Number analyzed for this baseline measure reflects data captured and does account for missing or unknown data.
|
PRIMARY outcome
Timeframe: 30 monthsThe primary outcome was whether or not patients participated in SDM regarding stent choice. Patients were categorized as having participated in SDM if they answered anything other than "doctor alone" in response to the question "Who chose the type of stent?"
Outcome measures
| Measure |
Pre-Implementation
n=336 Participants
Patients who undergo coronary angiography and possible percutaneous coronary intervention (PCI) received an Patient Risk Information Systems Manager (ePRISM) consent form with personalized risk estimates for mortality, bleeding, and target vessel revascularization (TVR) with bare-metal stents (BMS) and drug-eluting stents (DES), but neither the shared decision-making (SDM) tool nor decision coaching.
|
Post-implementation With Decision Coaching
n=113 Participants
Patients received the consent form, the SDM tool for stent selection, and decision coaching
|
Post-implementation Without Decision Coaching
n=137 Participants
Patients received the consent form and the SDM tool, but no decision coaching
|
|---|---|---|---|
|
Assessment of Pre-implementation, Post-implementation With Decision Coaching, and Post-implementation Without Decision Coaching
You alone
|
8 Participants
|
6 Participants
|
1 Participants
|
|
Assessment of Pre-implementation, Post-implementation With Decision Coaching, and Post-implementation Without Decision Coaching
Doctor Alone
|
235 Participants
|
45 Participants
|
106 Participants
|
|
Assessment of Pre-implementation, Post-implementation With Decision Coaching, and Post-implementation Without Decision Coaching
Mostly Doctor
|
51 Participants
|
19 Participants
|
20 Participants
|
|
Assessment of Pre-implementation, Post-implementation With Decision Coaching, and Post-implementation Without Decision Coaching
Mostly you
|
2 Participants
|
11 Participants
|
6 Participants
|
|
Assessment of Pre-implementation, Post-implementation With Decision Coaching, and Post-implementation Without Decision Coaching
Doctor and you equally
|
40 Participants
|
32 Participants
|
4 Participants
|
SECONDARY outcome
Timeframe: 30 monthsSecondary outcomes included patients' recall of individual aspects of the stent discussion, stent knowledge score, patient preference for stent type, perceived autonomy support from their providers ,and concordance of patient stent preference and type of stent received. Patients were categorized as having voiced a stent preference if they answered anything other than "I don't care" or "I don't know" in response to the question "After reviewing the risks and benefits of both types of stents, which type of stent did you want?"
Outcome measures
| Measure |
Pre-Implementation
n=336 Participants
Patients who undergo coronary angiography and possible percutaneous coronary intervention (PCI) received an Patient Risk Information Systems Manager (ePRISM) consent form with personalized risk estimates for mortality, bleeding, and target vessel revascularization (TVR) with bare-metal stents (BMS) and drug-eluting stents (DES), but neither the shared decision-making (SDM) tool nor decision coaching.
|
Post-implementation With Decision Coaching
n=113 Participants
Patients received the consent form, the SDM tool for stent selection, and decision coaching
|
Post-implementation Without Decision Coaching
n=137 Participants
Patients received the consent form and the SDM tool, but no decision coaching
|
|---|---|---|---|
|
Concordance Between Stent Preference and Stent Received Was a Secondary Outcome.
Drug eluting stent
|
83 Participants
|
49 Participants
|
23 Participants
|
|
Concordance Between Stent Preference and Stent Received Was a Secondary Outcome.
Bare metal stent
|
36 Participants
|
29 Participants
|
2 Participants
|
|
Concordance Between Stent Preference and Stent Received Was a Secondary Outcome.
I don't care
|
119 Participants
|
29 Participants
|
69 Participants
|
|
Concordance Between Stent Preference and Stent Received Was a Secondary Outcome.
I don't know
|
98 Participants
|
6 Participants
|
43 Participants
|
Adverse Events
Pre-Implementation
Post-implementation With Decision Coaching
Post-implementation Without Decision Coaching
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Carole Decker
Saint Luke's Mid America Heart Institute
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place